Annual EBITDA
-$61.98 M
-$321.00 K-0.52%
December 31, 2023
Summary
- As of February 8, 2025, RANI annual EBITDA is -$61.98 million, with the most recent change of -$321.00 thousand (-0.52%) on December 31, 2023.
- During the last 3 years, RANI annual EBITDA has fallen by -$46.02 million (-288.44%).
- RANI annual EBITDA is now -288.44% below its all-time high of -$15.96 million, reached on December 31, 2020.
Performance
RANI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$11.13 M
+$704.00 K+5.95%
September 30, 2024
Summary
- As of February 8, 2025, RANI quarterly EBITDA is -$11.13 million, with the most recent change of +$704.00 thousand (+5.95%) on September 30, 2024.
- Over the past year, RANI quarterly EBITDA has increased by +$704.00 thousand (+5.95%).
- RANI quarterly EBITDA is now -335.29% below its all-time high of -$2.56 million, reached on June 30, 2020.
Performance
RANI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$48.73 M
+$5.67 M+10.43%
September 30, 2024
Summary
- As of February 8, 2025, RANI TTM EBITDA is -$48.73 million, with the most recent change of +$5.67 million (+10.43%) on September 30, 2024.
- Over the past year, RANI TTM EBITDA has increased by +$5.67 million (+10.43%).
- RANI TTM EBITDA is now -839.55% below its all-time high of -$5.19 million, reached on March 31, 2020.
Performance
RANI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RANI EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.5% | +6.0% | +10.4% |
| 3 y3 years | -288.4% | +6.0% | +10.4% |
| 5 y5 years | -138.3% | +6.0% | +10.4% |
RANI EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.0% | at low | at high | +35.4% | at high | +31.4% |
| 5 y | 5-year | -288.4% | at low | -335.3% | +60.9% | -839.5% | +31.4% |
| alltime | all time | -288.4% | at low | -335.3% | +60.9% | -839.5% | +31.4% |
Rani Therapeutics Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.13 M(-6.0%) | -$48.73 M(-10.4%) |
| Jun 2024 | - | -$11.83 M(-10.6%) | -$54.40 M(-9.0%) |
| Mar 2024 | - | -$13.24 M(+5.6%) | -$59.78 M(-3.5%) |
| Dec 2023 | -$61.98 M(+0.5%) | -$12.53 M(-25.4%) | -$61.98 M(-6.0%) |
| Sep 2023 | - | -$16.80 M(-2.4%) | -$65.93 M(+1.5%) |
| Jun 2023 | - | -$17.21 M(+11.5%) | -$64.96 M(+2.4%) |
| Mar 2023 | - | -$15.44 M(-6.4%) | -$63.44 M(+2.9%) |
| Dec 2022 | -$61.66 M | -$16.49 M(+4.2%) | -$61.66 M(+5.6%) |
| Sep 2022 | - | -$15.82 M(+0.8%) | -$58.40 M(-17.8%) |
| Jun 2022 | - | -$15.69 M(+14.9%) | -$71.01 M(+17.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.65 M(+3.2%) | -$60.51 M(+16.2%) |
| Dec 2021 | -$52.08 M(+226.4%) | -$13.23 M(-53.5%) | -$52.08 M(+17.3%) |
| Sep 2021 | - | -$28.43 M(+448.2%) | -$44.40 M(+138.3%) |
| Jun 2021 | - | -$5.19 M(-0.8%) | -$18.63 M(+16.4%) |
| Mar 2021 | - | -$5.23 M(-5.6%) | -$16.00 M(+0.3%) |
| Dec 2020 | -$15.96 M(-38.7%) | -$5.54 M(+107.6%) | -$15.96 M(+53.2%) |
| Sep 2020 | - | -$2.67 M(+4.5%) | -$10.41 M(+34.5%) |
| Jun 2020 | - | -$2.56 M(-50.7%) | -$7.74 M(+49.3%) |
| Mar 2020 | - | -$5.19 M | -$5.19 M |
| Dec 2019 | -$26.01 M | - | - |
FAQ
- What is Rani Therapeutics Holdings annual EBITDA?
- What is the all time high annual EBITDA for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings annual EBITDA year-on-year change?
- What is Rani Therapeutics Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings quarterly EBITDA year-on-year change?
- What is Rani Therapeutics Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings TTM EBITDA year-on-year change?
What is Rani Therapeutics Holdings annual EBITDA?
The current annual EBITDA of RANI is -$61.98 M
What is the all time high annual EBITDA for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high annual EBITDA is -$15.96 M
What is Rani Therapeutics Holdings annual EBITDA year-on-year change?
Over the past year, RANI annual EBITDA has changed by -$321.00 K (-0.52%)
What is Rani Therapeutics Holdings quarterly EBITDA?
The current quarterly EBITDA of RANI is -$11.13 M
What is the all time high quarterly EBITDA for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high quarterly EBITDA is -$2.56 M
What is Rani Therapeutics Holdings quarterly EBITDA year-on-year change?
Over the past year, RANI quarterly EBITDA has changed by +$704.00 K (+5.95%)
What is Rani Therapeutics Holdings TTM EBITDA?
The current TTM EBITDA of RANI is -$48.73 M
What is the all time high TTM EBITDA for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high TTM EBITDA is -$5.19 M
What is Rani Therapeutics Holdings TTM EBITDA year-on-year change?
Over the past year, RANI TTM EBITDA has changed by +$5.67 M (+10.43%)